Epidemiological study of Candida infections in blood: susceptibilities of Candida spp. to antifungal agents, and clinical features associated with the candidemia
- 1 January 2006
- journal article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 12 (3) , 132-138
- https://doi.org/10.1007/s10156-006-0438-y
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Seminational Surveillance of Fungemia in Denmark: Notably High Rates of Fungemia and Numbers of Isolates with Reduced Azole SusceptibilityJournal of Clinical Microbiology, 2005
- Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic LocationJournal of Clinical Microbiology, 2003
- In Vitro Activities of Caspofungin Compared with Those of Fluconazole and Itraconazole against 3,959 Clinical Isolates of Candida spp., Including 157 Fluconazole-Resistant IsolatesAntimicrobial Agents and Chemotherapy, 2003
- In Vitro Activities of Voriconazole, Posaconazole, and Four Licensed Systemic Antifungal Agents against Candida Species Infrequently Isolated from BloodJournal of Clinical Microbiology, 2003
- Role of Sentinel Surveillance of Candidemia: Trends in Species Distribution and Antifungal SusceptibilityJournal of Clinical Microbiology, 2002
- Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis.Journal of Antimicrobial Chemotherapy, 2002
- Cross-Resistance of Clinical Isolates ofCandida albicansandCandida glabratato Over-the-Counter Azoles Used in the Treatment of VaginitisMicrobial Drug Resistance, 2000
- Practice Guidelines for the Treatment of CandidiasisClinical Infectious Diseases, 2000
- The Epidemiology of Candidemia in Two United States Cities: Results of a Population-Based Active SurveillanceClinical Infectious Diseases, 1999
- Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)Clinical Infectious Diseases, 1999